3 hours CG Oncology (NASDAQ:CGON) Coverage Initiated by Analysts at UBS GroupMarketBeat
UBS Group started coverage on shares of CG Oncology in a research report on Thursday. They set a “buy” rating and a $60.00 target price on the stock.
XUBS Group started coverage on shares of CG Oncology in a research report on Thursday. They set a “buy” rating and a $60.00 target price on the stock.
X